« Home « Chủ đề Sách nghiên cứu dược

Chủ đề : Sách nghiên cứu dược


Có 180+ tài liệu thuộc chủ đề "Sách nghiên cứu dược"

Pharmaceutical Substances Syntheses, Patents, Applications - Part 160

tailieu.vn

Use: adenosine deaminase inhibitor (for hairy cell leucemia treatment) RN MF: C,,H16N404 MW: 268.27. Use: vasodilator RN MF: C,,H,,N40, MW: 278.31 EINECS LD. 108 mglkg (M, i.v. RN MF: C,H31N03. 230 mglkg (M, p.0.);. 810 m g k g (R, p.0.) hydrochloride. RN MF: C,,H,,NO. 75 mglkg (M, i.v. 640 mglkg (M, p.0.);. RN MF: C,,,H,,N,S . RN MF: unspecified...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 161

tailieu.vn

61 mglkg (M, i.v. 270 mglkg (M, p.0.);. 60 mglkg (R, i.v.1. 660 mglkg (R, p.0.). 120 mglkg (M, p.0.);. 34.7 mglkg (M, i.v. 22.5 mglkg (R, i.v. 162 mglkg (R, p.0.). 4 mglkg (M, p.0.);. 5 mglkg (R, p.0.). 987 mglkg (M, p.0.);. 866 mglkg (M, p.0.);. wfm Novamon (Farge)-comb., USA: numerous combination. 254 mglkg (M, i.v. 832 mglkg...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 162

tailieu.vn

265 mglkg (M, p.0.). 268 mglkg (M, p.0.);. 520 mglkg (R, p.0.) p-aminosalicylate (1:l). comb.: wfm comb.. 218 mglkg (M, i.v. 226 mglkg (M, i.v. 200 mglkg (M, p a. 150 mg/kg (R, p.0.) calcium salt. 900 mglkg (M, p.0.). 71.04 glkg (R, p.0.) calcium salt (2:l). 840 mglkg (M, p.0.);. 11 10 m g k g (R, p.0.) CN:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 163

tailieu.vn

105mgkg(M,p.o.) CN: a,a-dimethylbenzeneethanamine. RN MF: C,"H,,N . HC1 MW: 185.70 EINECS LD. 154 mglkg (M, p.o.1;. 188 mglkg (R, p.o.). RN: 50-60-2 MF: C,,H19N,0 MW: 281.36 EINECS LD. RN: 73-05-2 MF: C,,H,,N,O - HCI MW: 317.82 EINECS LD. 75 mglkg (R, i.v. 1250 mglkg (R, p.0.). CH,O,S MW: 377.47 EINECS LD. 90 mglkg (M, i.v. 332 mg/kg (dog, p.0.) CN:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 164

tailieu.vn

RN MF: C,7H,N,02 MW: 424.63 LD,: 500 mglkg (M, i.p.). Use: anti-inflammatory RN MF: C,,H2,N203 MW: 276.34. Use: topical non-steroidal anti- inflammatory and analgesic, ketoprofen derivative RN MF: C22H20N202 MW: 344.41. RN MF: C,,H2,N202. Use: hypotensive, vasodilator RN MF: C8H,,N,0 MW: 197.24. 61.9 mglkg (M, i.v. 119 mglkg (M, p.0.);. 88.5 mglkg (R, i.v. 150 mglkg (M, i.v. 200 mglkg...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 165

tailieu.vn

Use: tranquilizer RN MF: ClxH,,ClN20 MW: 308.77 EINECS LD. Use: beta blocking agent RN MF: Cl,H,,N2O2 MW: 248.33 EINECS: 236-867-9. Use: antidiabetic, insulinenhancer RN MF: CL,H20N203S MW: 356.45. RN MF: C19H20N203S . ATC: NOSAW5 Use: neuroleptic RN MF: C2,H3,FN302 MW: 375.49. ATC: ROSDBI 1 Use: antitussive RN MF: C,,H,,N,O,S MW: 399.52 EINECS LD. RN MF: C2,H,5N303S . RN MF: C2,H3,N4O2...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 166

tailieu.vn

600 mgkg (M, p.0.);. 1340 mgkg (R, i.v. 1900 m g k g (R, p.0.) CN: piperazine. 4900 mgkg (R, p.0.). RN MF: C4Hl,N2 . 1 1200 mg/kg (R, p.0.) citrate (3:2) hydrate. RN MF: C6H80. RN MF: C10H14CaN20. RN MF: C,,H14CaN20c C4H,,N2. 7900 mgkg (R, p.0.). RN MF: C,,H2,N02 . 18.2 mgkg (M, i.v.);. Use: analgesic RN MF: C,,HZ3N3O...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 167

tailieu.vn

Use: peptic ulcer therapeutic RN MF: ClyH2,Ns02 MW: 35 1.41 EINECS: 249-228-4. RN MF: CIyH2,N,O2. 700 mglkg (R, i.v. Trade Name(s):. Use: vasodilator RN MF: Cl,H,,N402 MW: 298.35 EINECS: 222-764-6. RN MF: Cl,H18N402 . Use: psychotropic drug, cerebrostimulant RN MF: Cl,H,N20, MW: 340.38 EINECS . RN MF: C1,H24N20,~ C4H404 MW: 4.56.45 EINECS . 320 mglkg (R, p.0.). ATC: COlB Use:...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 168

tailieu.vn

10.10.1972. 4.10.1973. 6.10.1972).. Use: antibiotic RN MF: C2,H,,N,0sS MW: 439.58 EINECS: 251-276-6. RN MF: C2,H3,N305S . ATC: N02CXOI Use: antimigraine agent RN MF: C,,H,,NS MW: 295.45 EINECS: 239-632-9. RN MF: C,,H,,NS . Use: peptic ulcer therapeutic RN MF: C20Hqd02 MW: 306.49. 10.9 glkg (R, p.0.). 10.8.1987).. Use: local anesthetic, agent for sclerotherapy of varicose veins RN MF: C,,H,,O,, MW: 582.82...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 169

tailieu.vn

IJse: antispasmodic RN MF: C,,H,,N MW: 293.45. RN MF: CZIHz7N . 346 mglkg (M, p.0.);. Use: antiallergic, antiasthmatic, leukotriene D,-antagonist RN MF: C27HuNs04 MW: 481.51. RN MF: C2,H2,N504 . RN MF: C,,H,,N,NaO, MW: 503.49. RN MF: Cl,H,,NO, MW: 255.27 LD. 447 mglkg (M, p.0.);. RN MF: C26H4001 MW: 400.60 EINECS CN: (3P)-3-[(I-oxoheptyl)oxy]androst-5-en-17-one. RN MF: C,,H,,O, MW: 424.53. RN MF: C,,H,,NaO,...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 170

tailieu.vn

5.12.1973).. 4.12.1974. 11.7.1977. 13.12.1977. 30.9.1977).. 14.l2.1977. 14.12.1977. 25.2.1977. RN MF: C2,H3,0, MW. CN: (1 1 P)- 17-[(ethoxycarbonyl)oxy]-1 I-hydroxy-21-(I -oxopropoxy)pregna-1,4-diene-3,20-dione. Use: antineoplastic RN MF: C,5H45C12N0, MW: 646.65 EINECS LDs. CN bis(2-chloroethyl)arnino]phenyl]-I-oxobutoxy]-l1,17-dihydroxypregna-1,4-diene-3,20- dione. Use: glucocorticoid RN MF: C2,H3,N06 MW: 473.61 EINECS: 227-064-4. RN MF: C2,H3,N06 . 5 mg Trade Name(s):. S03BA02 Use: glucocorticoid RN: 50-24-8 MF: C21H280s MW: 360.45 EINECS: 200-021-7. CN...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 171

tailieu.vn

1 1 LJse: glucocorticoid RN MF: C,,H,,NO, MW: 485.62. RN MF: C,,H,,NO,. RN MF: C2,H,,05 MW: 416.56 EINECS acetate. RN MF: C2,H,,0, MW: 358.52 EINECS: 217-212-6. Use: cardiotonic RN MF: C,,H,,NO, MW: 225.29 EINECS CN: (S)-4-[2-hydroxy-3-[(1-rnethylethyl)arnino]propoxy]phenol. RN MF: C,,HI9NO3 . 250 mglkg (M, i.v.);. 250 mglkg (R, p.0.). 250 mglkg (M, p.0.);. RN MF: C2,HZ7N . I l mglkg (R,...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 172

tailieu.vn

LDso: 49 mglkg (M, i.v. 525 mglkg (M, p.0.);. 1 10 mglkg (R, i.v. 1950 mglkg (R, p.0.) CN: 4-amino-N-[2-(diethylamino)ethyl]benzamide monohydrochloride. 95 mglkg (R, i.v. 350 mglkg (M, p.0.):. HC1 MW: 272.78 EINECS LD. 175 mglkg (M, p.0.);. 38 mglkg (R, i.v. 614 mglkg (M, i.p.);. >400 mglkg (R, i.p. 540 mglkg (M, i.v. 350 mglkg (R, i.v. 570 mglkg...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 173

tailieu.vn

Use: progestogen RN MF: C24H3404 MW: 386.53 EINECS: 245-922-6. Trade Name(s):. RN MF: C,5H,,N . 230 mglkg (M, p.0.);. 40 1 mglkg (M, p.0.);. 400 mglkg (R, p.0.) maleate (2:l). RN MF: CL7H2,N2S . RN MF: C,,H2,N2S . Use: progestogen RN MF: C2,H3,02 MW: 326.48. 0.5 mg Trade Name(s):. Use: estrogen RN MF: C22H3202 MW: 328.50 EINECS CN: (17~)-17-methoxy-3-propoxyestra-1,3,5(10)-triene. 40...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 174

tailieu.vn

Trade Name(s):. Use: analgesic RN MF: C16H2sN,0 MW: 275.40 EINECS LD mglkg (M, s.c.);. RN MF: C,,H,,N,O . 874 mglkg (M, p.0.);. 30.10.1984. RN MF: C2,H,,N0, MW: 367.49. RN MF: C,,H2,N0,. 500 mg/kg (R, p.0.) CN: 2,6-bis(1-methylethy1)phenol. 9 mglkg (M, i.v.). RN MF: CloH21N . RN MF: CloH2,N MW: 155.29 EINECS hydrochloride. RN MF: C,oH21N. 70 mglkg (M, i.p.). 25...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 175

tailieu.vn

RN MF: CIhH19N3S . Use: tuberculostatic, antibacterial RN MF: C9H,,N2S MW: 180.28 EINECS: 238-093-7. Use: antidepressant, thyroid diagnostic RN MF: .C,,H2,N,O4 MW: 362.39 EINECS: 246-143-4. >5 g/kg (R, p.0.) CN: 5-0x0-L-prolyl-L-histidyl-L-prolinamide. 21.8.1973. Use: anti-inflammatory RN MF: Ci7H17N03S MW: 315.39 EINECS: 237-453-0. RN MF: CI9H2,N. RN MF: C,,H,SN,O MW: 287.41. RN MF: CI6H2&V2O3. Use: choleretic, antispasmodic RN MF: C,,H,,N MW: 293.45...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 176

tailieu.vn

RN MF: ClIHl4N,S . 123 mglkg (M, p.0.);. RN MF: CIIHl4N,S . C,,H,,O, M W 594.69 EINECS LD,: 62Q mglkg (M, ịp.1;. 2793 mglkg (M, s.c.) CN: pyrazinecarboxamide. Use: coronary vasodilator RN MF: C9H,2N406S . 16 mglkg (M, p.0.). LD,: 545 mglkg (M, ịv.);. 660 mglkg (M, ịv. 5500 mglkg (M, p.0.);. 92 mglkg (M, p.0.);. RN MF: Cl6HmN2O4S2. 5786...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 177

tailieu.vn

Use: central stimulant RN MF: C,,H,,NO MW: 245.37. RN MF: C,,H,,NO . Use: local anesthetic RN MF: C,,H,,,N20 MW: 232.33. RN MF: C,,HIoN,O . et al.: Acta Chem. Use: antibiotic, antifungal RN MF: C,,H,C12N,02 MW: 257.08 EINECS: 213-812-7. et al.: Tetrahedron Lett. et al.: Agric. ATC: PO2CX01 Use: anthelmintic RN MF: C2,HZ8Nc 112C2,H,40, W'W: 1151.42 EINECS LD. RN MF: C17H,lC1F4N2S...

Pharmaceutical Substances Syntheses, Patents, Applications - Part 178

tailieu.vn

1.10.1981. US Warner-Lambert. 20.2.1981 . 20.2.1981. 19.10.1987. Use: progestogen RN MF: C,H3,03 MW: 408.58 EINECS: 221-078-4. RN MF: C2,H3,02 MW: 366.55 EINECS: 234-199-2. 263 mg/kg (R, p.0.) CN: (9s)-6'-methoxycinchonan-9-01. RN MF: C,,H,N,O,. RN MF: CzoHz4N2O2 . RN MF: C2,H,,N202 . RN MF: C20H24N202. RN MF: Cl,H2,N20 . Use: antidepressant RN MF: C2,H2,N2 MW: 304.44 EINECS: 250-780-3. RN MF. 20.4.1998).. 10.7.1998....

Pharmaceutical Substances Syntheses, Patents, Applications - Part 179

tailieu.vn

et al.: J. et al.: Org. 30.8.1995. 31.8.1994).. 20.7.1995. 19.4.1983. 18.4.1996. 21.4.1995).. 20.3.1996. 19.3.1996).. 30.4.1996. 28.8.1996).. 16.5.1995. 20.5.1994).. 19.9.1995. 19.9.1994).. 19.9.1986. 14.2.1996. 27.2.1995).. Gardner et al.: J. Use: antihypertensive (ACE inhibitor) RN MF: C23H32N20s MW: 416.52. et al.: Arzneim.-Forsch. Use: anti-emetic, 5-HT,-antagonist RN MF: CI7H,,N3O. RN MF: C,7H,7N,0 MW: 279.34. et al.: Chem. Dellweg et al.: Biochem. 45.7 mglkg (M,...